Center for Scientific Review; Notice of Closed Meeting, 10639 [2016-04446]
Download as PDF
<![CDATA[
10639
Federal Register / Vol. 81, No. 40 / Tuesday, March 1, 2016 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondents
Number of
respondents
per year
Form name
Phase 2: Summer Curriculum
in Cancer Prevention.
Phase 1: Women’s Cancer
Program Summit.
Phase 2: Women’s Cancer
Program Summit.
Phase 1: Regional Grant Writing and Peer Review Workshop.
Phase 2: Regional Grant Writing and Peer Review Workshop.
Phase 1: Workshops on Tobacco Control.
Phase 2: Workshops on Tobacco Control.
Totals ..................................................
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR13–189:
Imaging and Biomarkers for Early Cancer
Detection.
Date: March 22, 2016.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
VerDate Sep<11>2014
20:18 Feb 29, 2016
Jkt 238001
1
30/60
14
140
1
20/60
47
140
1
20/60
47
150
1
30/60
75
60
1
30/60
30
180
1
30/60
90
90
1
30/60
45
2,317
2,317
........................
941
Contact Person: Chiayeng Wang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Room 5213, MSC 7852, Bethesda, MD 20892,
301–435–2397, chiayeng.wang@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
[FR Doc. 2016–04363 Filed 2–29–16; 8:45 am]
Dated: February 25, 2016.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–04446 Filed 2–29–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; iWin: Navigating Your Path to
Well-Being
Summary: In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Institute on Drug Abuse
(NIDA), National Institutes of Health
(NIH), will publish periodic summaries
of proposed projects to be submitted to
the Office of Management and Budget
(OMB) for review and approval.
Written comments and/or suggestions
from the public and affected agencies
are invited to address one or more of the
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
Total annual
burden hours
27
..................................................
Dated: February 10, 2016.
Karla Bailey,
Project Clearance Liaison, National Cancer
Institute, NIH.
Average
burden per
response
(in hours)
Number of
responses per
respondent
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
To Submit Comments And For
Further Information: To obtain a copy of
the data collection plans and
instruments, submit comments in
writing, or request more information on
the proposed project, contact: Dr.
Belinda Sims, Health Scientist, DESPR,
PRB, NIDA, NIH, 6001 Executive
Boulevard, Room 5153, Bethesda,
Maryland 20892, or call non-toll-free
number (301) 402–1533, or Email your
request, including your address to:
bsims@nida.nih.gov. Formal requests for
additional plans and instruments must
be requested in writing.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Proposed Collection: iWin: Navigating
your Path to Well-Being, 0925–NEW,
National Institute on Drug Abuse
(NIDA), National Institutes of Health
(NIH).
Need and Use of Information
Collection: The overarching objective of
this proposal is to conduct a
E:\FR\FM\01MRN1.SGM
01MRN1
]]>Agencies
[Federal Register Volume 81, Number 40 (Tuesday, March 1, 2016)]
[Notices]
[Page 10639]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-04446]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR13-189: Imaging and Biomarkers for Early Cancer Detection.
Date: March 22, 2016.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Chiayeng Wang, Ph.D., Scientific Review Officer,
Center for Scientific Review, 6701 Rockledge Drive, Room 5213, MSC
7852, Bethesda, MD 20892, 301-435-2397, chiayeng.wang@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: February 25, 2016.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-04446 Filed 2-29-16; 8:45 am]
BILLING CODE 4140-01-P
